DIASORIN S.P.A. financials
DIASORIN S.P.A.
Country: IT Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
8156002878BDF0EE4348 Financial statements
(EUR, as reported — unscaled; 99 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €1.20B | €1.19B |
| Cost of sales | €421.6M | €403.7M |
| Gross profit | €773.5M | €781.7M |
| Operating profit (EBIT) | €228.6M | €258.3M |
| Finance costs | €25.4M | €28.8M |
| Profit before tax | €211.6M | €242.4M |
| Income tax expense | €61.6M | €55.4M |
| Profit for the year | €150.0M | €187.1M |
| — attributable to owners | €155.6M | €188.1M |
| — attributable to NCI | -€5.6M | -€1.0M |
| Total comprehensive income | -€65.4M | €273.7M |
| Per share | ||
| Basic EPS | €2.92 | €3.35 |
| Diluted EPS | €2.85 | €3.35 |
| Free cash flow / share | €5.34 | €5.49 |
| Cash flow statement | ||
| Cash generated from operations | €388.5M | €390.7M |
| Net cash from operating activities | €342.8M | €358.8M |
| Net cash from investing activities | -€144.5M | -€49.8M |
| Purchase of PP&E (capex) | €61.7M | €52.1M |
| Purchase of intangibles | €76.0M | €67.6M |
| Net cash from financing activities | -€351.2M | -€259.1M |
| Dividends paid | €63.5M | €61.3M |
| Balance sheet | ||
| Total assets | €2.87B | €3.30B |
| Non-current assets | €2.09B | €2.34B |
| Property, plant & equipment | €255.9M | €271.4M |
| Intangible assets & goodwill | €754.2M | €846.9M |
| Current assets | €785.1M | €967.2M |
| Inventories | €334.6M | €344.0M |
| Trade & other receivables | €200.7M | €194.7M |
| Cash & equivalents | €165.8M | €344.3M |
| Total equity | €1.58B | €1.80B |
| — attributable to owners | €1.58B | €1.80B |
| Non-controlling interests | -€7.7M | -€1.9M |
| Non-current liabilities | €790.6M | €1.23B |
| Current liabilities | €505.8M | €275.3M |
| Deferred tax liabilities | €196.5M | €199.6M |
| Derived metrics | ||
| Free cash flow | €281.0M | €306.7M |
| Operating margin | 19.1% | 21.8% |
| Net margin | 12.6% | 15.8% |
| Return on equity | 9.5% | 10.4% |
| Cash conversion ratio | 2.28× | 1.92× |
| Capex coverage | 5.55× | 6.88× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €34.1M | -€17.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | €5.1M | €8.7M |
| Adjustments For Depreciation and Amortisation Expense | €128.2M | €129.0M |
| Adjustments For Finance Income Cost | -€17.0M | -€15.9M |
| Adjustments For Income Tax Expense | €61.6M | €55.4M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€48.0K | -€27.0K |
| Adjustments For Increase Decrease In Trade Account Payable | €14.8M | €1.6M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €68.0K | €1.8M |
| Adjustments For Provisions | -€449.0K | -€874.0K |
| Adjustments For Sharebased Payments | €11.1M | €11.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€30.2M | -€44.0M |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | -€3.8M | €19.6M |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits and Investments | -€12.1M | €67.2M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €333.5M | €374.9M |
| Comprehensive Income Attributable To Noncontrolling Interests | -€5.8M | -€1.3M |
| Comprehensive Income Attributable To Owners of Parent | -€59.6M | €275.0M |
| Current Financial Assets | €45.9M | €49.0M |
| Current Financial Liabilities | €257.5M | €47.8M |
| Current Tax Liabilities Current | €26.5M | €18.1M |
| Deferred Tax Assets | €36.9M | €31.6M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €63.5M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.15 | — |
| Dividends Recognised As Distributions To Owners Per Share | €1.15 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€25.5M | €14.1M |
| Equity and Liabilities | €2.87B | €3.30B |
| Finance Income | €8.5M | €12.9M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€207.8M | €100.9M |
| General and Administrative Expense | €124.9M | €128.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €47.4M | €33.1M |
| Increase Decrease In Cash and Cash Equivalents | -€178.5M | €64.0M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Exercise of Options | €21.7M | €11.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -€107.3M | — |
| Increase Decrease Through Treasury Share Transactions | €860.0K | €37.6M |
| Intangible Assets Other Than Goodwill | €1.04B | €1.18B |
| Issued Capital | €55.9M | €55.9M |
| Liabilities | €1.30B | €1.51B |
| Noncurrent Financial Assets | €0 | €3.6M |
| Noncurrent Financial Liabilities | €533.9M | €966.8M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €26.0K | €26.0K |
| Noncurrent Provisions For Employee Benefits | €30.5M | €31.9M |
| Other Comprehensive Income | -€215.4M | €86.7M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€8.7M | -€15.3M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €1.2M | €1.1M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€216.6M | €85.6M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €1.2M | €1.1M |
| Other Current Assets | €38.1M | €35.2M |
| Other Current Payables | €112.9M | €109.9M |
| Other Noncurrent Assets | €5.4M | €2.7M |
| Other Noncurrent Liabilities | €8.0M | €9.6M |
| Other Operating Income Expense | -€40.7M | -€16.0M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €5.3M | €2.7M |
| Research and Development Expense | €95.0M | €91.6M |
| Sales and Marketing Expense | €284.4M | €287.7M |
| Share Premium | €18.2M | €18.2M |
| Statutory Reserve | €11.2M | €11.2M |
| Trade and Other Current Payables To Trade Suppliers | €108.8M | €99.5M |
| Treasury Shares | €343.3M | €251.8M |
Methodology
Every line item above is a fact tagged in DIASORIN S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.